{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lupron&page=2", "query": { "condition": "Lupron", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lupron&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-05-22T05:43:29.223Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01642186", "title": "Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fibrolamellar Carcinoma", "Fibrolamellar Liver Cancer" ], "interventions": [ { "name": "everolimus", "type": "DRUG" }, { "name": "letrozole plus leuprolide", "type": "DRUG" }, { "name": "combination of everolimus, letrozole and leuprolide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 28, "start_date": "2012-07-12", "completion_date": "2021-07-16", "has_results": true, "last_update_posted_date": "2022-12-29", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 6, "location_summary": "San Francisco, California • Baltimore, Maryland • Boston, Massachusetts + 1 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01642186" }, { "nct_id": "NCT01813370", "title": "A Registry for Patients Treated on the Clinical Trial TAX 3503", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 52, "start_date": "2013-03", "completion_date": "2022-03-04", "has_results": false, "last_update_posted_date": "2022-03-08", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 5, "location_summary": "Baltimore, Maryland • New York, New York • Durham, North Carolina + 2 more", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Lancaster", "state": "Pennsylvania" }, { "city": "Myrtle Beach", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01813370" }, { "nct_id": "NCT05096065", "title": "Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Endometriosis" ], "interventions": [ { "name": "Leuprolide Oral Tablet - 120 mg - QD- Treatment A", "type": "DRUG" }, { "name": "Leuprolide Oral Tablet - 80 mg - QD - Treatment B", "type": "DRUG" }, { "name": "Leuprolide Oral Tablet - 60 mg - QD - Treatment C", "type": "DRUG" }, { "name": "Leuprolide Oral Tablet - 60 mg - BID - Treatment D", "type": "DRUG" }, { "name": "Leuprolide Oral Tablet - 40 mg - BID - Treatment E", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Enteris BioPharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "18 Years to 49 Years · Female only" }, "enrollment_count": 16, "start_date": "2022-03-18", "completion_date": "2022-05", "has_results": false, "last_update_posted_date": "2022-03-22", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 4, "location_summary": "Sarasota, Florida • Columbus, Ohio • Norfolk, Virginia + 1 more", "locations": [ { "city": "Sarasota", "state": "Florida" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Norfolk", "state": "Virginia" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05096065" }, { "nct_id": "NCT04051320", "title": "Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Perinatal Depression", "Post Partum Depression", "Depression, Postpartum", "Depression" ], "interventions": [ { "name": "Leuprolide Acetate 3.75 MG/ML", "type": "DRUG" }, { "name": "Estradiol 2 Mg tablet", "type": "DRUG" }, { "name": "Micronized progesterone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "22 Years to 45 Years · Female only" }, "enrollment_count": 23, "start_date": "2020-01-02", "completion_date": "2022-07-19", "has_results": true, "last_update_posted_date": "2023-08-25", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04051320" }, { "nct_id": "NCT00429494", "title": "GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Amenorrhea", "Premature Ovarian Failure", "Ovarian Function Insufficiency" ], "interventions": [ { "name": "Leuprolide Acetate", "type": "DRUG" }, { "name": "Questionnaire", "type": "BEHAVIORAL" }, { "name": "Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "40 Years", "sex": "FEMALE", "summary": "Up to 40 Years · Female only" }, "enrollment_count": 60, "start_date": "2002-11", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2013-07-09", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00429494" }, { "nct_id": "NCT02203331", "title": "Bay98-7196, Dose Finding / POC Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Endometriosis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Levonorgestrel", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Lupron / Leuprolide acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 319, "start_date": "2014-10-16", "completion_date": "2016-10-24", "has_results": true, "last_update_posted_date": "2023-11-07", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 25, "location_summary": "San Diego, California • San Francisco, California • Gainesville, Florida + 22 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "New Port Richey", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02203331" }, { "nct_id": "NCT03649724", "title": "The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer Disease", "Mild Cognitive Impairment" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Eligard 22.5Mg Suspension for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "120 Years", "sex": "FEMALE", "summary": "60 Years to 120 Years · Female only" }, "enrollment_count": 180, "start_date": "2020-11-27", "completion_date": "2026-07-01", "has_results": false, "last_update_posted_date": "2025-08-01", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 3, "location_summary": "Boca Raton, Florida • New York, New York • Madison, Wisconsin", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "New York", "state": "New York" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03649724" }, { "nct_id": "NCT00220194", "title": "A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cancer of Prostate" ], "interventions": [ { "name": "leuprolide acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "San Bernardino Urological Associates Medical Group Inc", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 100, "start_date": "2003-04", "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2016-10-14", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 1, "location_summary": "San Bernardino, California", "locations": [ { "city": "San Bernardino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00220194" }, { "nct_id": "NCT05605964", "title": "Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Relugolix", "type": "DRUG" }, { "name": "Leuprolide Acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 387, "start_date": "2023-01-25", "completion_date": "2025-01-02", "has_results": false, "last_update_posted_date": "2025-08-17", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 108, "location_summary": "Mobile, Alabama • Tucson, Arizona • Little Rock, Arkansas + 83 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05605964" }, { "nct_id": "NCT00001412", "title": "Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hypogonadism" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "MALE", "summary": "Male only" }, "enrollment_count": 70, "start_date": "1993-12", "completion_date": "2001-11", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-05-22T05:43:29.223Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001412" } ] }